Personalised medicine made in hospitals can revolutionise the way diseases are treated – the challenge now will be implementing it

By Irina Brass, Associate Professor in Regulation, Innovation and Public Policy, UCL
Edison Bicudo, Research Fellow Biopharmaceutical Regulation, UCL
Penny Carmichael, Policy Adviser, Faculty of Engineering Science, UCL

Imagine a patient with a rare genetic disorder that makes their arms and legs have imprecise and slow movements. For years, the patient has faced serious restrictions in day-to-day life. They tried several treatments, but all have failed to ease the symptoms.

Now imagine a university team discovering a therapy that could tackle this condition, with a solution that lies in the patient’s own body. The patient’s blood would be collected, some key cells would be separated in a laboratory, gene-editing techniques would be applied, and personalised medicine, produced with specialised equipment,…

Read complete article

~	In Brazil, the intelligence services spied on over 300,000 citizens during the military dictatorship

~	Dark matter: our new experiment aims to turn the ghostly substance into actual light

~	The politics stopping the UK from opening a youth mobility scheme with Europe

~	Tarantino abandons his tenth film – five other times Hollywood giants cancelled big projects

~	Jordan has long been a beacon of stability in the Middle East – but that looks to be changing

~	Male baldness is often trivialised – our research shows it should be taken seriously

~	To tackle climate change Labour must rebuild the planning system – not ‘bulldoze’ it

~	US drugs regulator gives LSD ‘breakthrough’ status for treating anxiety – why this is so significant

~	I contributed to the Misogyny In Music report – it’s sadly unsurprising that its recommendations have been rejected

~	Spotify just made a record profit. What can the platform do now to maintain momentum?